Page
%P
-
Article
Open AccessCorrection to: The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data
-
Article
Open AccessThe genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data
Neoadjuvant chemotherapy (NACT) becomes the first-line option for advanced tumors, while patients who are not sensitive to it may not benefit. Therefore, it is important to screen patients suitable for NACT.